Trial intelligence / Profile preview

Dexmedetomidine and ONSD in Severe Pre-eclampsia

NCT05610774Completed

Sponsor
Benha University
Start
Jun 2023
Primary completion
May 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in severe preeclampsia (2 arms), sponsored by Benha University. Primary endpoint: Optic Nerve Sheath Diameter at 24 hours. Started Jun 2023; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

severe preeclampsia

Beyond the preview

Go deeper on NCT05610774.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05610774.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call